These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35997036)

  • 21. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
    Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
    Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.
    Pinkhardt EH; Jürgens R; Becker W; Valdarno F; Ludolph AC; Kassubek J
    J Neurol; 2008 Dec; 255(12):1916-25. PubMed ID: 19224319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.
    Wittstock M; Pohley I; Walter U; Grossmann A; Benecke R; Wolters A
    J Neural Transm (Vienna); 2013 Mar; 120(3):453-61. PubMed ID: 22892823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy.
    Ma J; Zhang G; Zhao Z; Chan P; Ye Z
    Brain Behav; 2024 Jul; 14(7):e3606. PubMed ID: 38945805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy.
    Quattrone A; Crasà M; Morelli M; Vescio B; Augimeri A; Gramigna V; Quattrone A
    Parkinsonism Relat Disord; 2022 Jun; 99():84-90. PubMed ID: 35642995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
    Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gait Analysis in Progressive Supranuclear Palsy Phenotypes.
    Picillo M; Ricciardi C; Tepedino MF; Abate F; Cuoco S; Carotenuto I; Erro R; Ricciardelli G; Russo M; Cesarelli M; Barone P; Amboni M
    Front Neurol; 2021; 12():674495. PubMed ID: 34177779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
    Necpál J; Borsek M; Jeleňová B
    Neurol Sci; 2021 Dec; 42(12):4927-4936. PubMed ID: 34532773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Boston Qualitative Scoring System as a measure of executive functioning in Rey-Osterrieth Complex Figure performance.
    Somerville J; Tremont G; Stern RA
    J Clin Exp Neuropsychol; 2000 Oct; 22(5):613-21. PubMed ID: 11094396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy.
    Picillo M; Cuoco S; Carotenuto I; Abate F; Erro R; Volpe G; Pellecchia MT; Catricalà E; Cappa S; Barone P
    PLoS One; 2019; 14(10):e0223621. PubMed ID: 31603934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic potential of automated tractography in progressive supranuclear palsy variants.
    Potrusil T; Krismer F; Beliveau V; Seppi K; Müller C; Troger F; Göbel G; Steiger R; Gizewski ER; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2020 Mar; 72():65-71. PubMed ID: 32113070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE; Williams DR; Anderson JF
    J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G; Agosta F; Kostić VS; Stojković T; Pagani E; Stošić-Opinćal T; Filippi M
    Mov Disord; 2011 Feb; 26(2):247-55. PubMed ID: 21412831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative Evaluation of the Immediate Copy of the Rey-Osterrieth Complex Figure: Comparison Between Vascular and Degenerative MCI Patients.
    Salvadori E; Dieci F; Caffarra P; Pantoni L
    Arch Clin Neuropsychol; 2019 Feb; 34(1):14-23. PubMed ID: 29420698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.